Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Balchem Corporation/ 8-K

Current Report · Items 2.02, 9.01 · 8-K

Balchem Corporation

BCPCNASDAQEQUITYCurrent

Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition On July 31, 2026, Balchem Corporation reported earnings for the quarter ended June 30, 2026, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1.…

Filed Jul 31, 2026Accepted Jul 31, 2026, 7:32 AM EDTCIK 9326Accession 0000009326-26-000026
View company →Permanent SEC source ↗
Share

Company context

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-ofthe-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Current securities

BCPCNASDAQ · EQUITY · Current

Recent company filings

  1. 10-Q filingJul 31, 2026
  2. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementJul 27, 2026
  3. Submission of Matters to a Vote of Security HoldersJun 22, 2026
  4. 11-K filingJun 18, 2026
  5. 10-Q filingApr 30, 2026

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition On July 31, 2026, Balchem Corporation reported earnings for the quarter ended June 30, 2026, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.